The Law Offices of Frank R. Cruz Announces Investigation of Bioventus ...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 23, 2024

Coeur Publishes 2023 ESG Report • Carter’s, Inc. to Report First Quarter Fiscal 2024 Results on Friday, April 26, 2024 • Popilush Introduces Bluetag COOLING Collection with Body-Cooling Technology • Forbes Magazine Recognizes RTI International As One Of The Best Employers For Diversity • PENN Entertainment Publishes 2023 Corporate Social Responsibility Report • TELUS Health 2024 Drug Trends Report: Diabetes medications maintain top reimbursed expense position; ADHD drugs surge • Northeast Delta HSA collaborates with AKA chapter for Earth Day, plants tree to symbolize RISE Center • Zurn Elkay Water Solutions Reports First Quarter 2024 Financial Results • American Foundation for Suicide Prevention Statement on the Release of the 2024 National Strategy for Suicide Prevention • Avangrid First Quarter 2024 Financial Results Available on Company’s Website • HGreg Joins Forces With Tree Canada for an 8th Consecutive Year • Experience Senior Living Celebrates the Opening of the new Independent Living community at The Gallery at Cape Coral • Minister Sudds highlights budget investments in support of Indigenous Reconciliation • Nerdy to Announce First Quarter 2024 Results on May 7, 2024 • AudioEye Reports Record First Quarter 2024 Results • AccountTECH unveils revolutionary Cloud-Based Enterprise Accounting software at the T3 Leadership Summit • Tesla Releases First Quarter 2024 Financial Results • Empire State Realty Trust Publishes 2023 Sustainability Report with Major Achievements, Key Goals, and Transparent Metrics • Brookdale Announces Date of First Quarter 2024 Earnings Release and Conference Call • Gateway First Bank Receives National Certification by Banking Advocates as Offering a Safe, Affordable Personal Checking Account

The Law Offices of Frank R. Cruz Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors

LOS ANGELES , November 29 /Businesswire/ - The Law Offices of Frank R. Cruz announces an investigation of Bioventus Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

In February 2021, Bioventus conducted its initial public offering ("IPO"), selling 8 million shares of Class A common stock at $13 per share.

Then, on November 16, 2022, Bioventus issued a press release announcing that it could not timely file its quarterly report for the period ended October 1, 2022. Bioventus was "seeking resolution related to the validity of a revised invoice" regarding "rebate claims [that it received] from a large private payer in relation to our Pain Treatments vertical, which likely will adversely affect the Company's previously announced third quarter 2022 financial results." Moreover, the Company had determined preliminarily that it was required to record a non-cash impairment charge in the range of $185 million to $205 million. As a result, Bioventus disclosed that "its internal controls related to the timely recognition of quarterly rebates were inadequate."

On this news, Bioventus's stock price fell $1.00 per share, or 33.67%, to close at $1.97 per share on November 17, 2022, representing a total decline of 84.85% from the IPO price.

If you purchased Bioventus securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.